Clinical Trial Update: Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating DuoTrav as replacement therapy for glaucoma and ocular hypertension in Russia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: WITHDRAWN